Tabacon, Crishsaffiah .

HRN: 28-93-06  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2026
CEFUROXIME 1.5GM (VIAL)
04/30/2026
05/07/2026
IV
250mg
Q8h
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: